| BCBS Highmark Penn Medicare Advantage | Biomarkers Overview | 2024-01-01 |
| BCBS Highmark Penn Medicare Advantage | Valoctocogene Roxaparvovec-rvox (Roctavian) | 2024-01-01 |
| BCBS Highmark NY and West NY | Extracorporeal Shock Wave Therapy for Musculoskeletal Conditions and Soft Tissue Wounds | 2024-01-01 |
| BCBS Highmark NY and West NY | Vertebral Body Tethering | 2024-01-01 |
| BCBS Highmark Delaware | Extracorporeal Shock Wave Therapy for Musculoskeletal Conditions and Soft Tissue Wounds | 2024-01-01 |
| BCBS Highmark Delaware | Entranacogene dezaparvovec (Hemgenix) | 2024-01-01 |
| BCBS Highmark West Virginia | Extracorporeal Shock Wave Therapy for Musculoskeletal Conditions and Soft Tissue Wounds | 2024-01-01 |
| BCBS Highmark West Virginia | Vertebral Body Tethering | 2024-01-01 |
| BCBS Highmark West Virginia | Entranacogene dezaparvovec (Hemgenix) | 2024-01-01 |
| Sunshine Health Clinical Policy | Wheelchair Seating | 2024-01-01 |